Aerovate Therapeutics Number of Employees 2020-2024 | JBIO

Aerovate Therapeutics number of employees from 2020 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Aerovate Therapeutics Annual Employee Count
2024 4
2023 51
2022 43
2021 16
2020 8
2019 N/A
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.008B $0.000B
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.
Stock Name Country Market Cap PE Ratio
SAG Holdings (INEO) Singapore $0.014B 0.00
NAYA Biosciences (IVF) United States $0.002B 0.00